Furazobol, known by its trade name, Miotolan, is a synthetic derivative
of dihydrotestosterone. Until 1990 this steroid was not detectable during
any doping tests and could thus be taken by athletes even on the day of a
competition. When looking at the application of Miotolan you learn even more
unusual things: This steroid is used as a lipid reducer. It is suitable for
long-term treatment of arteriosclerosis and hypercholesterolemia.
Miotolan reduces the cholesterol level and increases the "good" HDL
value. In Japan Miotolan is a standard treatment to lower cholesterol
levels. This steroid does not cause water and salt retention and does not
aromatize. Since the tablets are effective for only a brief period of time
they must be taken several times a day. Miotolan as a predominantly
androgenic effect and only a very low repression of the body's own
testosterone production. Although it is potentially hepatoxic a possible
reduced liver function seems unlikely if the daily manufacturer recommended
dose of 2-6 mg is not exceeded. Since athletes use considerably higher
dosages the risk of liver poisoning cannot be excluded. The usual
question-What is a performance improving dosage is difficult to answer. It
is difficult because we do not know anybody who has ever taken this compound
and because technical literature does not have anything to report in this
regard either. The daily dosage should be at least 10-20 tablets, that is
10-20 mg/day. Due to its low substance amount per tablet and its high cost,
this steroid will probably not be successful with body-builders. (Possible
doubts by readers that this steroid perhaps does not exist are
inappropriate.) However, this steroid really does exist.
Return to Profiles |